Abstract:SUMMARY: Senile osteoporosis is mainly caused by reduced osteoblast differentiation and has become the leading cause of fractures in the elderly worldwide. Natural organics are emerging as a potential option for the prevention and treatment of osteoporosis. This study was designed to study the effect of resveratrol on osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) in osteoporosis mice. A mouse model of osteoporosis was established by subcutaneous injection of dexamethasone and treated with resveratrol administered by gavage. In vivo and in vitro, we used western blot to detect protein expression, and evaluated osteogenic differentiation of BMSCs by detecting the expression of osteogenic differentiation related proteins, calcium deposition, ALP activity and osteocalcin content. Resveratrol treatment significantly increased the body weight of mice, the level of serum Ca2+, 25(OH)D and osteocalcin, ration of bone weight, bone volume/total volume, trabecular thickness, trabecular number, trabecular spacing and cortical thickness in osteoporosis mice. In BMSCs of osteoporosis mice, resveratrol treatment significantly increased the expression of Runx2, osterix (OSX) and osteocalcin (OCN) protein, the level of calcium deposition, ALP activity and osteocalcin content. In addition, resveratrol treatment also significantly increased the expression of SIRT1, p-PI3K / PI3K and p-AKT / AKT in BMSCs of osteoporosis mice. In vitro, resveratrol increased the expression of SIRT1, p-PI3K / PI3K and p-AKT / AKT, Runx2, OSX and OCN protein, the level of calcium deposition, ALP activity and osteocalcin content in BMSCs in a concentration-dependent manner, while SIRT1 knockdown significantly reversed the effect of resveratrol. Resveratrol can attenuate osteoporosis by promoting osteogenic differentiation of bone marrow mesenchymal stem cells, and the mechanism may be related to the regulation of SIRT1/PI3K/AKT pathway. RESUMEN: La osteoporosis senil es causada principalmente por una diferenciacin reducida de osteoblastos y se ha convertido en la principal causa de fracturas en las personas mayores en todo el mundo. Los productos orgnicos naturales estn surgiendo como una opcin potencial para la prevencin y el tratamiento de la osteoporosis. Este estudio fue diseado para estudiar el efecto del resveratrol en la diferenciacin osteognica de las clulas madre mesenquimales de la mdula sea (BMSC) en ratones con osteoporosis. Se estableci un modelo de osteoporosis en ratones mediante inyeccin subcutnea de dexametasona y se trat con resveratrol administrado por sonda. In vivo e in vitro, utilizamos Western blot para detectar la expresin de protenas y evaluamos la diferenciacin osteognica de BMSC detectando la expresin de protenas relacionadas con la diferenciacin osteognica, la deposicin de calcio, la actividad de ALP y el contenido de osteocalcina. El tratamiento con resveratrol aument significativamente el peso corporal de los ratones, el nivel srico de Ca2+, 25(OH)D y osteocalcina, la proporcin de peso seo, el volumen seo/ volumen total, el espesor trabecular, el nmero trabecular, el espaciado trabecular y el espesor cortical en ratones con osteoporosis. En BMSC de ratones con osteoporosis, el tratamiento con resveratrol aument significativamente la expresin de las protenas Runx2, osterix (OSX) y osteocalcina (OCN), el nivel de deposicin de calcio, la actividad de ALP y el contenido de osteocalcina. Adems, el tratamiento con resveratrol tambin aument significativamente la expresin de SIRT1, p-PI3K/PI3K y p-AKT/AKT en BMSC de ratones con osteoporosis. In vitro, el resveratrol aument la expresin de las protenas SIRT1, p-PI3K/PI3K y p- AKT/AKT, Runx2, OSX y OCN, el nivel de deposicin de calcio, la actividad de ALP y el contenido de osteocalcina en BMSC de manera dependiente de la concentracin, mientras que La cada de SIRT1 revirti significativamente el efecto del resveratrol. El resveratrol puede atenuar la osteoporosis al promover la diferenciacin osteognica de las clulas madre mesenquimales de la mdula sea, y el mecanismo puede estar relacionado con la regulacin de la va SIRT1/PI3K/AKT.

Resveratrol induces proliferation and differentiation of mouse pre-osteoblast MC3T3-E1 by promoting autophagy

PI3K/AKT pathway involvement in the osteogenic effects of osteoclast culture supernatants on preosteoblast cells.

[Effect of the Bone Resorption Supernatant from RAW264.7 Osteoclast on the Osteogenic Activity of Mouse MC3T3-E1 Cell].

Resveratrol regulates skeletal muscle fibers switching through the AdipoR1-AMPK-PGC-1α pathway.

Resveratrol induces proliferation in preosteoblast cell MC3T3-E1 via GATA-1 activating autophagy

Resveratrol protects MC3T3-E1 cells against cadmium-induced suppression of osteogenic differentiation by modulating the ERK1/2 and JNK pathways

Resveratrol promotes osteoblastic differentiation in a rat model of postmenopausal osteoporosis by regulating autophagy

Resveratrol Enhances Proliferation and Osteoblastic Differentiation in Human Mesenchymal Stem Cells Via Er-Dependent Erk1/2 Activation

Effect of Trans-resveratrol on the Differentiation of Osteoclast Induced from Bone Marrow in Mice

Resveratrol Synergistically Promotes BMP9-Induced Osteogenic Differentiation of Mesenchymal Stem Cells

[Effects of Resveratrol on Aging of Mesenchymal Stem Cells and Its Mechanism].

Resveratrol Alleviates Osteoporosis by Promoting Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells via SITR1/PI3K/AKT Pathway

Resveratrol promotes osteogenesis and alleviates osteoporosis by inhibiting p53

Resveratrol Promotes Osteogenic Differentiation of Canine Bone Marrow Mesenchymal Stem Cells Through Wnt/Beta-Catenin Signaling Pathway

Resveratrol improves osteogenic differentiation of senescent bone mesenchymal stem cells through inhibiting endogenous reactive oxygen species production via AMPK activation

Resveratrol suppresses lipopolysaccharide-mediated activation of osteoclast precursor RAW 264.7 cells by increasing miR-181a-5p expression

The Role and Mechanism of SIRT1 in Resveratrol-regulated Osteoblast Autophagy in Osteoporosis Rats

Resveratrol Protects Osteoblasts Against Dexamethasone-Induced Cytotoxicity Through Activation of AMP-Activated Protein Kinase

Resveratrol prevents steroid‐induced osteonecrosis of the femoral head via miR‐146a modulation

Puerarin Promotes the Viability and Differentiation of MC3T3-E1 Cells by Enhancing LC3B-mediated Autophagy Through Downregulation of Mir-204

Protective effect of resveratrol on estrogen deficiency-induced osteoporosis though attenuating NADPH oxidase 4/nuclear factor kappa B pathway by increasing miR-92b-3p expression